Professor Christoph A. Nienaber is a consultant cardiologist at Royal Brompton Hospital and a certified internist, cardiologist, and interventional cardiovascular specialist with significant experience in advanced cardiovascular care. He developed his academic career at University Medical Center Hamburg-Eppendorf and undertook a temporary post at UCLA School of Medicine. He chaired internal medicine and cardiology at Universitätsmedizin Rostock until May 2015, when he took up his position at Royal Brompton Hospital in the Heart Division & Aortic Centre. His research and clinical activities focus on the diagnosis and non-surgical treatment of acute and chronic aortic pathologies, including aneurysms and aortic dissection. He is a co-founder of the International Registry of Aortic Dissection (IRAD), has pioneered endovascular techniques for aortic dissection, and has initiated and participated in guideline-changing trials. He also serves on various guideline committees in Europe. His research interests include structural and coronary heart disease, TAVI, complex PCI and calcium modification, TEVAR, left-atrial appendage occlusion, patent foramen ovale, atrial septal defect II occlusion, and non-surgical management of aortic coarctation and malformations. He has published more than 730 peer-reviewed scientific papers and a number of book chapters, serves on the editorial boards of several journals, and has an H-factor of 119.
Professor Christoph A. Nienaber is a consultant cardiologist at Royal Brompton Hospital and a certified internist, cardiologist, and interventional cardiovascular specialist with significant experience in advanced cardiovascular care. He developed his academic career at University Medical Center Hamburg-Eppendorf and undertook a temporary post at UCLA School of Medicine. He chaired internal medicine and cardiology at Universitätsmedizin Rostock until May 2015, when he took up his position at Royal Brompton Hospital in the Heart Division & Aortic Centre. His research and clinical activities focus on the diagnosis and non-surgical treatment of acute and chronic aortic pathologies, including aneurysms and aortic dissection. He is a co-founder of the International Registry of Aortic Dissection (IRAD), has pioneered endovascular techniques for aortic dissection, and has initiated and participated in guideline-changing trials. He also serves on various guideline committees in Europe. His research interests include structural and coronary heart disease, TAVI, complex PCI and calcium modification, TEVAR, left-atrial appendage occlusion, patent foramen ovale, atrial septal defect II occlusion, and non-surgical management of aortic coarctation and malformations. He has published more than 730 peer-reviewed scientific papers and a number of book chapters, serves on the editorial boards of several journals, and has an H-factor of 119.